Tilray is a drug manufacturers - specialty & generic business based in the US. Tilray shares (TLRY) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.31 – a decrease of 9.03% over the previous week. Tilray employs 2,650 staff and has a trailing 12-month revenue of around $812 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.31 |
|---|---|
| 52-week range | $1.33 - $2.97 |
| 50-day moving average | $1.66 |
| 200-day moving average | $1.82 |
| Wall St. target price | $2.21 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.27 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.32 from 2024-11-18
| 1 week (2024-11-13) | -8.33% |
|---|---|
| 1 month (2024-10-18) | -16.98% |
| 3 months (2024-08-20) | -29.41% |
| 6 months (2024-05-20) | -31.96% |
| 1 year (2023-11-20) | -27.27% |
|---|---|
| 2 years (2022-11-18) | -65.80% |
| 3 years (2021-11-19) | 10.93 |
| 5 years (2019-11-20) | 20.92 |
Valuing Tilray stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tilray's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tilray's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $31.1 million.
The EBITDA is a measure of a Tilray's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $812 million |
|---|---|
| Gross profit TTM | $116.8 million |
| Return on assets TTM | -1.4% |
| Return on equity TTM | -5.84% |
| Profit margin | -26.18% |
| Book value | $3.97 |
| Market Capitalization | $1.2 billion |
TTM: trailing 12 months
We're not expecting Tilray to pay a dividend over the next 12 months.
Tilray's shares were split on a 0.8381:1 basis on 2 May 2021 . So if you had owned 1 share the day before before the split, the next day you'd have owned 0.8381 shares. This wouldn't directly have changed the overall worth of your Tilray shares – just the quantity. However, indirectly, the new 19.3% higher share price could have impacted the market appetite for Tilray shares which in turn could have impacted Tilray's share price.
Over the last 12 months, Tilray's shares have ranged in value from as little as $1.33 up to $2.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tilray's is 2.188. This would suggest that Tilray's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Tilray Brands, Inc. , a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc.
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.